Eritema tóxico neonatal
Revisado por Dr Philippa Vincent, MRCGPÚltima atualização por Dr Colin Tidy, MRCGPÚltima atualização 24 Jul 2023
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
Profissionais de Saúde
Os artigos de Referência Profissional são projetados para uso por profissionais de saúde. Eles são escritos por médicos do Reino Unido e baseados em evidências de pesquisa, diretrizes do Reino Unido e da Europa. Você pode encontrar o Eritema tóxico neonatal artigo mais útil, ou um dos nossos outros artigos de saúde.
Synonyms: erythema neonatorum allergicum; toxic erythema of the newborn
O que é eritema tóxico neonatal?1
Eritema tóxico neonatal (ETN) only occurs in the newborn, usually presenting within the first week of life. It has the appearance of small, erythematous papules and vesicles. Occasionally pustules also occur. The lesions are often surrounded by areas of diffuse blotchy erythema, giving the appearance of a distinct halo.
Individual lesions are quite transient and usually disappear quickly, only to be replaced by others in different parts of the body. The condition is benign, causes no symptoms and resolves spontaneously, usually within 7-14 days.
Fisiopatologia
The condition has been known throughout the ages and was described by ancient Mesopotamian physicians.2 The exact cause is not known but some authorities have attributed it to an allergy because of the prominence of eosinophils within the lesions. Some popular theories include:
An immune system reaction involving hair follicles (the condition normally occurs on hair-bearing areas and clusters of mast cells can be seen around hair follicles).3
An innate immune response against commensal colonisation by organisms such as Group B streptococcus.4 .
Over-expression of high mobility group box chromosomal protein 1 (HMGP-1), a proinflammatory cytokine released by macrophages and keratinocytes4
A transient adjustment reaction of the newborn skin to mechanical or thermal stimulation.2
How common is erythema toxicum neonatorum? (Epidemiology)
A Spanish study reported a prevalence of 16.7%,5 a Turkish study reported a prevalence of 13%6 and an Indian study 23%.7 There is considerable geographical variation. A Chinese study estimated prevalence to be about 44%.8
Fatores de risco
Studies have identified the following risk factors:5 8
Caucasian race.
Higher birth weight.
Greater gestational age.
Maternal age less than 30 years.
Term birth.
The birth season (higher in summer and autumn).
Feeding with milk powder substitute or a mixed diet.
The length of labour in vaginal delivery.
Some studies suggest it is more common in male infants and in babies born to women who have had two or fewer pregnancies; however, other studies have contradicted these findings.
Erythema toxicum neonatorum symptoms (presentation)8
The typical rash appears in newborns between the ages of 3 days to 2 weeks. Rarely, it can occur within the first 48 hours. The transience of the lesions is characteristic; they can appear or disappear within minutes to hours.
The lesions most commonly start on the trunk and involve the buttocks and proximal parts of the limbs.5 The face can also become involved.1
Diagnóstico diferencial1 8
Sepse neonatal.
Miliaria.
Investigações1
The characteristic appearance of the lesions, their fleeting nature and the lack of systemic features make the condition fairly easy to diagnose clinically.
If the clinical picture is atypical, material taken from a pustule should be examined to exclude bacterial, viral and fungal infections.
A peripheral blood film may show eosinophilia.
If systemic sepsis is suspected, blood cultures should be taken to exclude Group B streptococcus, Listeria spp., Escherichia coli and other pathogens.
If necessary, a skin biopsy should be taken. Typically, there is accumulation of primary eosinophils. Other features may be neutrophils in the follicular epithelium, hyperkeratosis and follicular plugging.
Erythema toxicum neonatorum treatment2
The condition is self-limiting and requires no treatment. Parents should be reassured about this but advised to report any atypical features.
Complicações2
No complications occur. Despite the presence of eosinophils within the lesions, no links to atopic conditions have been established.
Prognóstico2
Full resolution is expected within two weeks of onset. 11% of patients develop a recurrence six weeks later.
Atualizações exclusivas para profissionais de saúde
Mantenha-se informado com as últimas atualizações clínicas, insights profissionais e orientações baseadas em evidências. O boletim informativo Patient Pro seleciona conteúdo essencial para profissionais de saúde—entregue diretamente na sua caixa de entrada.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.
Leitura adicional e referências
- Eritema tóxico do recém-nascido; DermNet.
- Roques E, Ward R, Mendez MD; Eritema Tóxico. StatPearls, Jan 2023.
- Mahajan VK, Sharma NL; Erythema toxicum neonatorum. Indian Pediatr. 2010 Sep;47(9):793.
- Morgan AJ, Steen CJ, Schwartz RA, et al; Erythema toxicum neonatorum revisited. Cutis. 2009 Jan;83(1):13-6.
- Marchini G, Stabi B, Kankes K, et al; AQP1 and AQP3, psoriasin, and nitric oxide synthases 1-3 are inflammatory mediators in erythema toxicum neonatorum. Pediatr Dermatol. 2003 Sep-Oct;20(5):377-84.
- Yamasaki O, Manabe K, Morimoto A, et al; Pustular erythema toxicum neonatorum in two siblings born to a mother with group B streptococcus colonization. Eur J Dermatol. 2011 Mar-Apr;21(2):271-2. doi: 10.1684/ejd.2010.1229.
- Monteagudo B, Labandeira J, Cabanillas M, et al; Prospective study of erythema toxicum neonatorum: epidemiology and predisposing factors. Pediatr Dermatol. 2012 Mar-Apr;29(2):166-8. doi: 10.1111/j.1525-1470.2011.01536.x. Epub 2011 Nov 8.
- Ekiz O, Gul U, Mollamahmutoglu L, et al; Skin findings in newborns and their relationship with maternal factors: observational research. Ann Dermatol. 2013 Feb;25(1):1-4. doi: 10.5021/ad.2013.25.1.1. Epub 2013 Feb 14.
- Haveri FT, Inamadar AC; A cross-sectional prospective study of cutaneous lesions in newborn. ISRN Dermatol. 2014 Jan 20;2014:360590. doi: 10.1155/2014/360590. eCollection 2014.
- Liu C, Feng J, Qu R, et al; Epidemiologic study of the predisposing factors in erythema toxicum neonatorum. Dermatology. 2005;210(4):269-72.
Sobre o revisorVer biografia completa

Dr Philippa Vincent, MRCGP
Médico Generalista, Autor Médico
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
Dra Philippa Vincent é um médico do NHS trabalhando no norte de Londres.
Mais em pediatria
- Campilobacteriose
- Paralisia cerebral
- Problemas comportamentais comuns em crianças
- Crupe
- Incesto
- Infecção do trato respiratório inferior em crianças
- Síndrome de aspiração de mecônio
- Icterícia neonatal
- Transtorno de pesadelo
- Fimose e parafimose
- Porfirias
- Síndrome de Potter
- Subluxação da cabeça do rádio
- Rubéola
- Exame do bebê de seis semanas
- Espinha bífida
- Gestão do estado de mal epiléptico
- Morte fetal e neonatal
- Torção do testículo
- Tumor de Wilms


